Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse

被引:45
作者
Jayasimhan, Abhirup [1 ]
Mansour, Kristy P. [1 ]
Slattery, Robyn M. [1 ]
机构
[1] Monash Univ, Alfred Hosp Med Res & Educ Precinct AMREP, Dept Immunol, Melbourne, Vic 3004, Australia
关键词
autoimmunity; immunopathogenesis; insulitis; non-obese diabetic mouse (NOD mouse); Type 1 diabetes (T10); PANCREATIC LYMPH-NODES; DIABETOGENIC T-CELLS; INTERCELLULAR-ADHESION MOLECULE-1; CLASS-II MOLECULE; MHC CLASS-I; BETA-CELLS; B-CELLS; RECENT-ONSET; DENDRITIC CELLS; CYTOKINE PRODUCTION;
D O I
10.1042/CS20120627
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
T1D (Type 1 diabetes) is an autoimmune disease caused by the immune-mediated destruction of pancreatic beta-cells. Studies in T1D patients have been limited by the availability of pancreatic samples, a protracted pre-diabetic phase and limitations in markers that reflect beta-cell mass and function. The NOD (non-obese diabetic) mouse is currently the best available animal model of T1D, since it develops disease spontaneously and shares many genetic and immunopathogenic features with human T1D. Consequently, the NOD mouse has been extensively studied and has made a tremendous contribution to our understanding of human T1D. The present review summarizes the key lessons from NOD mouse studies concerning the genetic susceptibility, aetiology and immunopathogenic mechanisms that contribute to autoimmune destruction of beta-cells. Finally, we summarize the potential and limitations of immunotherapeutic strategies, successful in NOD mice, now being trialled in T1D patients and individuals at risk of developing T1D.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 187 条
[1]   Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleuldn-1 Blockade [J].
Ablamunits, Vitaly ;
Henegariu, Octavian ;
Hansen, Jakob Bondo ;
Opare-Addo, Lynn ;
Preston-Hurlburt, Paula ;
Santamaria, Pere ;
Mandrup-Poulsen, Thomas ;
Herold, Kevan C. .
DIABETES, 2012, 61 (01) :145-154
[2]   Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice [J].
Akashi, T ;
Nagafuchi, S ;
Anzai, K ;
Kondo, S ;
Kitamura, D ;
Wakana, S ;
Ono, J ;
Kikuchi, M ;
Niho, Y ;
Watanabe, T .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (08) :1159-1164
[3]   Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains -: Elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-α and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice [J].
Alleva, DG ;
Pavlovich, RP ;
Grant, C ;
Kaser, SB ;
Beller, DI .
DIABETES, 2000, 49 (07) :1106-1115
[4]   CD107a as a functional marker for the identification of natural killer cell activity [J].
Alter, G ;
Malenfant, JM ;
Altfeld, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 294 (1-2) :15-22
[5]   The NOD mouse: A model of immune dysregulation [J].
Anderson, MS ;
Bluestone, JA .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :447-485
[6]   Checkpoints in the progression of autoimmune disease: Lessons from diabetes models [J].
Andre, I ;
Gonzalez, A ;
Wang, B ;
Katz, J ;
Benoist, C ;
Mathis, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2260-2263
[7]  
[Anonymous], 2012, CSH PERSPECT MED, DOI [10.1101/cshperspect.a007682, DOI 10.1101/cshperspect.a007682]
[8]   The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Ansari, MJI ;
Salama, AD ;
Chitnis, T ;
Smith, RN ;
Yagita, H ;
Akiba, H ;
Yamazaki, T ;
Azuma, M ;
Iwai, H ;
Khoury, SJ ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :63-69
[9]   T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes [J].
Babad, Jeffrey ;
Geliebter, Ari ;
DiLorenzo, Teresa P. .
IMMUNOLOGY, 2010, 131 (04) :459-465
[10]   Activation of natural killer cells:: Underlying molecular mechanisms revealed [J].
Backström, E ;
Kristensson, K ;
Ljunggren, HG .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 60 (1-2) :14-22